Baseline Characteristics and Interim Month 12 mNAPSI Results in Patients with Moderate-to- Severe Plaque Psoriasis and Concomitant Nail Psoriasis Treated with Biologics in the Psoriasis Study of Health Outcomes (PSoHO)

被引:0
|
作者
Egeberg, Alexander [1 ]
Pinter, Andreas [2 ]
Vender, Ronald [3 ]
Zaheri, Shirin [4 ]
Brnabic, Alan [5 ]
Schuster, Christopher [5 ,6 ]
Elrayes, Mohamed [5 ]
Reed, Catherine [5 ]
Riedl, Elisabeth [6 ]
Puig, Luis [7 ]
机构
[1] Copenhagen Univ Hosp, Dept Dermatol, Copenhagen, Denmark
[2] Univ Hosp Frankfurt, Clin Dermatol Venereol & Allergol, Frankfurt, Germany
[3] Dermatrials Res Inc, Hamilton, ON, Canada
[4] HCA Healthcare, London, England
[5] Eli Lilly & Co, Indianapolis, IN USA
[6] Med Univ Vienna, Dept Dermatol, Vienna, Austria
[7] Univ Autonoma Barcelona, Dept Dermatol, IIB SANT PAU, Hosp Santa Creu & Sant Pau, Barcelona, Spain
关键词
D O I
暂无
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
42592
引用
下载
收藏
页码:AB127 / AB127
页数:1
相关论文
共 50 条
  • [31] Impact of baseline characteristics on the efficacy of ixekizumab in patients with moderate to severe psoriasis in a phase 2 study
    Papp, Kim
    Zhu, Baojin
    Leonardi, Craig
    Cameron, Gregory
    Erickson, Janelle
    Heffernan, Michael
    Banerjee, Subhashis
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2014, 70 (05) : AB171 - AB171
  • [32] Baseline characteristics according to previous exposure to systemic treatment in patients with moderate to severe psoriasis: Results from the PROSE study
    Augustin, Matthias
    Dauden, Esteban
    Mrowietz, Ulrich
    Paul, Carle
    Rissler, Michael
    Gathmann, S.
    Sieder, Christian
    Bachuber, Teresa
    Orsenigo, Roberto
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (04) : AB175 - AB175
  • [33] Characteristics and disease burden in patients with mild to moderate vs severe plaque psoriasis in real-world settings: Results from the Corrona Psoriasis Registry
    Strober, Bruce
    Cronin, Angel
    Lin, Tin-Chi
    O'Brien, Jaqueline
    Emeanuru, Kelechi
    Kang, Hyung-Joo
    Gomez, Natalie Nunez
    Khilfeh, Ibrahim
    Lebwohl, Mark
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB113 - AB113
  • [34] THE PSORIASIS STUDY OF HEALTH OUTCOMES (PSOHO) IN BIOLOGIC-NAIVE AND -EXPERIENCED PATIENTS: RESULTS FROM THE FIRST 217 PATIENTS
    Costanzo, A.
    Pinter, A.
    Lynde, C.
    Tsai, T. F.
    Schuster, C.
    Brnabic, A.
    Reed, C.
    Hill, J.
    Riedl, E.
    Radtke, M. A.
    VALUE IN HEALTH, 2020, 23 : S410 - S410
  • [35] High induction dosing of risankizumab in patients with moderate-to-severe plaque psoriasis: Interim results from the phase 2 KNOCKOUT study
    Blauvelt, A.
    Gudjonsson, J.
    Matheson, R.
    Liu, R.
    Shi, L.
    Photowala, H.
    Ehst, B.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2023, 143 (09) : B16 - B16
  • [36] Patients with moderate to severe plaque psoriasis show improvement in patient satisfaction with etanercept therapy: a 12-week interim analysis
    de Rie, M. A.
    Griffiths, C. E. M.
    Desris, T. A.
    Robertson, D.
    Freundlich, B.
    Chang, D. J.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2007, 21 : 57 - 57
  • [37] Apremilast in moderate to severe plaque psoriasis: 32-week results in patients with nail, scalp, and palmoplantar involvement (ESTEEM 2)
    Sebastian, M.
    Crowley, J.
    Cather, J.
    Gooderham, M.
    Girolomoni, G.
    Ferrandiz, C.
    Hu, C. C.
    Day, R.
    Beylot-Barry, M.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2015, 13 : 94 - 95
  • [38] Safety of Biologic Therapies in Patients with Moderate-to-Severe Plaque Psoriasis and Concomitant Viral Hepatitis: A Monocentric Retrospective Study
    Luigi Gargiulo
    Giulia Pavia
    Mario Valenti
    Ana Lleo de Nalda
    Chiara Perugini
    Antonio Costanzo
    Alessandra Narcisi
    Dermatology and Therapy, 2022, 12 : 1263 - 1270
  • [39] Safety of Biologic Therapies in Patients with Moderate-to-Severe Plaque Psoriasis and Concomitant Viral Hepatitis: A Monocentric Retrospective Study
    Gargiulo, Luigi
    Pavia, Giulia
    Valenti, Mario
    de Nalda, Ana Lleo
    Perugini, Chiara
    Costanzo, Antonio
    Narcisi, Alessandra
    DERMATOLOGY AND THERAPY, 2022, 12 (05) : 1263 - 1270
  • [40] Real-world outcomes in patients with moderate-to-severe plaque psoriasis treated with guselkumab for up to 1 year
    Galluzzo, Marco
    Talamonti, Marina
    Bernardini, Nicoletta
    Chiricozzi, Andrea
    De Simone, Clara
    Bonifati, Claudio
    Bruni, Pierluigi
    Diotallevi, Federico
    Esposito, Maria
    Graceffa, Dario
    Hansel, Katharina
    Loconsole, Francesco
    Moretta, Gaia
    Mugheddu, Cristina
    Papini, Manuela
    Richetta, Antonio
    Skroza, Nevena
    Atzori, Laura
    Fargnoli, Maria Concetta
    Persechino, Severino
    Offidani, Annamaria
    Stingeni, Luca
    Peris, Ketty
    Potenza, Concetta
    Bianchi, Luca
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2022, 22 (12) : 1585 - 1592